王建华
奥曲肽与凝血酶联合治疗肝硬化合并上消化道出血的临床分析
王建华
【摘要】目的 分析奥曲肽与凝血酶联合治疗肝硬化合并上消化道出血的临床疗效。方法 研究2015年1~11月纳入肝硬化合并上消化道出血患者45例,数字法分组。21例选择奥曲肽治疗,为对照组;其余24例联合运用奥曲肽余凝血酶,为实验组。组间比较。结果 两组中实验组的输血量更少,止血时间更短,住院日更短,治疗有效率更高,差异有统计学意义(P<0.05)。结论 肝硬化合并上消化道出血患者经过奥曲肽与凝血酶联合治疗,止血快速,疗效显著。
【关键词】肝硬化;上消化道出血;奥曲肽;凝血酶
Objective Clinical effect of octreotide combined with thrombin in treatment of liver cirrhosis complicated by upper gastrointestinal bleeding is to be studied. Methods Chose 45 patients of liver cirrhosis complicated by upper gastrointestinal bleeding that were treated in hospital from January 2015 to November 2015 and separated them into two groups according to digits,21 patients in control group were given octreotide treatment,while 24 patients in study group were given octreotide combined with thrombin treatment,and then observed and compared patients’ treatment effects between two groups. Results Patients’ blood-transfusion consumption was less,hemostasis time was shorter,their hospitalization days were fewer and treatment efficacy was higher in study group,there was a differential between two groups and such a differential had statistic value(P<0.05). Conclusion Octreotide combined with Thrombin is effective in treatment of liver cirrhosis complicated by upper gastrointestinal bleeding,it is conducive to stopping hemorrhage with efficacy.
【Key words】 Liver cirrhosis,Upper gastrointestinal bleeding,Octreotide,Thrombin
肝硬化在临床上常见,由多种或1种病因长期且反复作用造成的肝损害,呈弥漫性特点,相关病因有酒精性、免疫性、病毒性及胆源性等。该病并发症多,以上消化道出血极为常见,一旦合并此症,出血量迅猛,治疗不当或不及时可危及个体生命[1]。此文研究2015年1~11月纳入肝硬化合并上消化道出血患者45例,总结奥曲肽联合凝血酶治疗方法及治疗效果,汇报见下。
1.1 一般资料
研究2015年1~11月纳入肝硬化合并上消化道出血患者45例,数字法分组。21例选择奥曲肽治疗,为对照组,出血量平均(640.56±36.47)ml,年龄24~76岁,平均(54.13±2.44)岁,女患者有7例,14例男患者。其余24例联合运用奥曲肽余凝血酶,为实验组,出血量平均(633.48±39.55)ml,年龄24~75岁,平均(54.35±2.23)岁,女患者有8例,16例男患者。两组均有黑便、呕血等,经肝功能检查及胃镜检查确诊,并排除血友病、严重心肝肾疾病、精神疾病及药物过敏者。……